| scholarly article | Q13442814 |
| P2093 | author name string | KALOW W | |
| GUNN DR | |||
| D. R. GUNN | |||
| W. KALOW | |||
| P2860 | cites work | Studies on cholinesterase: 1. Cholinesterase and pseudo-cholinesterase | Q42577351 |
| Electrophoretic Separation and Classification of Blood Plasma Esterases | Q59090851 | ||
| A method for the detection of atypical forms of human serum cholinesterase; determination of dibucaine numbers | Q74522898 | ||
| The relation between dose of succinylcholine and duration of apnea in man | Q74612912 | ||
| A Nocturnal Tendency in Phrynosoma platyrhinos | Q95617774 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | statistics | Q12483 |
| genetics | Q7162 | ||
| P304 | page(s) | 239-250 | |
| P577 | publication date | 1959-07-01 | |
| P1433 | published in | Annals of Human Genetics | Q4767852 |
| P1476 | title | Some statistical data on atypical cholinesterase of human serum | |
| P478 | volume | 23 |
| Q35232147 | A pseudocholinesterase variant (E Cynthiana) associated with elevated plasma enzyme activity |
| Q35897801 | APNEA DUE TO INHERITANCE OF ATYPICAL PSEUDOCHOLINESTERASE |
| Q34632512 | Agar diffusion test for serum cholinesterase typing and influence of temperature on dibucaine and fluoride numbers. |
| Q71701508 | Amino acid sequence of the active site of human pseudocholinesterase |
| Q69585900 | Amino acid sequence of the active site of human serum cholinesterase from usual, atypical, and atypical-silent genotypes |
| Q36637011 | An original approach to the diagnosis of scoline-induced apnoea |
| Q76465782 | Antibody to enzymes--a three-component system. Introduction: immunochemistry of enzymes |
| Q44572618 | Apnea due to succinyldicholine: study of a French-Canadian population |
| Q52754075 | Atypical Cholinesterase Gene E 1 a : Rarity in Negroes and Most Orientals |
| Q40063825 | Atypical pseudocholinesterase activity: A review and presentation of two cases |
| Q79317983 | Butyrylcholinesterase and obesity in individuals with the CHE2 C5+ and CHE2 C5- phenotypes |
| Q46218562 | Butyrylcholinesterase identification in a phenylvalerate esterase-enriched fraction sensitive to low mipafox concentrations in chicken brain. |
| Q34077223 | COMPLETE PSEUDOCHOLINESTERASE DEFICIENCY: GENETIC AND IMMUNOLOGIC CHARACTERIZATION. |
| Q35025518 | Cardiovascular pharmacogenomics and individualized drug therapy |
| Q52231214 | Chicken retinospheroids as developmental and pharmacological in vitro models: acetylcholinesterase is regulated by its own and by butyrylcholinesterase activity. |
| Q35201435 | Cholinesterase Newfoundland: a new succinylcholine-sensitive variant of cholinesterase at locus 1 |
| Q39727791 | Cholinesterase phenotyping: clinical aspects and laboratory applications |
| Q37687076 | Cholinesterases during development of the avian nervous system |
| Q67693840 | Clinical pharmacokinetics of muscle relaxants |
| Q35232200 | Discrimination of phenotypes in human serum cholinesterase deficiency |
| Q72699575 | Enzyme studies in young patients with scoliosis |
| Q76586935 | FAMILIAL SENSITIVITY TO SUXAMETHONIUM DUE TO ATYPICAL PSEUDOCHOLINESTERASE |
| Q35231085 | Factors influencing cholinesterase activity in a Brazilian population |
| Q93761777 | Familial Pseudocholinesterase Deficiency |
| Q59086881 | Frequency of Atypical Pseudocholinesterase in British and Mediterranean Populations |
| Q59086873 | Frequency of the Atypical Pseudocholinesterase in Four Indian (Mexican) Tribes |
| Q40001374 | Genetic regulation of plasma cholinesterase in man |
| Q46566431 | Genetics of esterases in man |
| Q37509093 | Genomic Disparities in Breast Cancer Among Latinas. |
| Q35257645 | Height and weight in cystic fibrosis: a cross sectional study. UK Cystic Fibrosis Survey Management Committee |
| Q79056528 | Heterogeneity of ceruloplasmin |
| Q70439607 | High frequency of atypical pseudocholinesterase gene among Iraqi and Iranian Jews* |
| Q41985354 | Human pharmacogenomics: the development of a science |
| Q93728146 | Human population frequencies in twelve blood grouping systems |
| Q52765264 | INCIDENCE OF PSEUDOCHOLINESTERASE VARIANTS IN AUSTRALIAN ABORIGINES. |
| Q24626519 | Identification of the structural mutation responsible for the dibucaine-resistant (atypical) variant form of human serum cholinesterase |
| Q34009746 | Isozymes of lactic dehydrogenase in human tissues |
| Q36429849 | Molecular biological search for human genes encoding cholinesterases. |
| Q39326939 | On the geographical distribution of pseudocholinesterase variants |
| Q72952990 | On the significance and technic of determining hereditary pseudocholinesterase variants |
| Q24676585 | POLYMORPHISMS OF THE SERUM PROTEINS AND THE DEVELOPMENT OF ISO-PRECIPITINS IN TRANSFUSED PATIENTS |
| Q34453112 | Pharmacogenetic screening and therapeutic drugs |
| Q33600016 | Pharmacogenetics as a molecular basis for individualized drug therapy: the thiopurine S-methyltransferase paradigm |
| Q38221179 | Pharmacogenetics of antiretroviral therapy |
| Q23919667 | Pharmacogenetics, pharmacogenomics, and individualized medicine |
| Q35861076 | Pharmacogenetics. Cholinesterase variants and suxamethonium apnoea. |
| Q34137575 | Pharmacogenomics: a systems approach |
| Q33267767 | Production of the butyrylcholinesterase knockout mouse. |
| Q51865684 | Prolonged apnea after orthognathic surgery due to atypical cholinesterase. |
| Q71020402 | Prolonged apnea caused by inherited cholinesterase deficiency after strabismus surgery |
| Q50702396 | Proposed nomenclature for human butyrylcholinesterase genetic variants identified by DNA sequencing. |
| Q39892641 | Pseudocholinesterase Activity and Phenotypes in Mentally Ill Patients |
| Q59086970 | Pseudocholinesterase Variants in Japan |
| Q59086878 | Pseudocholinesterase-variants in Germany and Czechoslovakia |
| Q72363875 | Pseudocholinesterase-variants in Thailand and Japan |
| Q76625073 | SEROLOGICAL DEMONSTRATION OF ANTIGENIC HETEROGENEITY OF INDIVIDUAL HUMAN GAMMA-1-MACROGLOBULINS |
| Q41882496 | Serum albumin, pseudocholine-sterase, and transaminases in the assessment of liver function before and after venous shunt operations |
| Q35912488 | Serum cholinesterase levels in families and twins. |
| Q72849962 | Studies on Serum Pseudocholinesterase in Glaucoma* |
| Q42433288 | THE "SILENT" GENE FOR SERUM CHOLINESTERASE. |
| Q72754523 | The diagnostic value of serum enzyme measurements |
| Q48711655 | The importance of being marginal: Norma Ford Walker and a Canadian school of medical genetics. |
| Q52732305 | The recognition of atypical plasma cholinesterase by relative substrate hydrolysis rate |
| Q67451283 | The relation of sex, age, smoking status, birth rank and parental ages to pseudocholinesterase activity and phenotypes in a sample of Australian Caucasian adults |
| Q52759160 | The substrate specificity of atypical cholinesterase in relation to phenotypes |
| Q81244699 | Treating individuals 2. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation |
| Q84947934 | Two Further Serum Pseudocholinesterase Phenotypes as Causes of Suxamethonium Apnoea |
| Q79029634 | Unusual responses to drugs in some hereditary conditions |
| Q36729620 | Various pharmacogenetic aspects of antiepileptic drug therapy: a review |
| Q69988840 | [Population genetic studies on pseudocholinesterase variants in Hungary and Germany] |
| Q79097757 | [The modern concept of genes in human genetics] |
Search more.